BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 5, 2005
View Archived Issues
MN-001 shows a good safety profile in healthy volunteers
Read More
Dosing begins in phase I study of CCR5 mAb in HIV patients
Read More
StemCells works to lift clinical hold on proposed phase I study of HuCNS-SC
Read More
PRX-03140 enters phase Ib studies for Alzheimer's
Read More
Theratechnologies plans phase III trials for ThGRF
Read More
Rigel completes phase I study of R-406
Read More
Adenosine A2A receptor agonist/PDE IV inhibitor combination therapy enhances cardioprotection
Read More
Antidepressants inhibit steroid transporters and evoke negative feedback on the HPA axis
Read More
Sucampo submits lubiprostone NDA
Read More
PTC-124 receives fast track status for cystic fibrosis
Read More
Sanofi pasteur's new polio vaccine licensed for use
Read More
Yamanouchi and Fujisawa form Astellas Pharma
Read More
Antiangiogenic actions of oral lenalidomide in rats
Read More
New analgesic agents developed at GSK and Euroceltique
Read More
Valentis initiates phase IIb study of VLTS-934 for peripheral arterial disease
Read More
Memory nominates new drug candidate MEM-63908
Read More
Genentech claims new treatments for immunological disorders
Read More
Landmark study evaluates Provacel stem cell product in cardiac patients
Read More
Antibacterial CY-403 enters preclinical testing
Read More
Chinese launch of Bilive vaccine
Read More
4SC concludes phase I studies for SC-12267
Read More
GSK discloses novel antiinflammatory glucocorticosteroids
Read More
Outline of products under development by MediciNova
Read More
FDA approves Asmanex for once daily management of asthma
Read More
New data on the anxiolytic effects of pregabalin in patients with GAD
Read More
New intravenous formulation of Nexium receives FDA approval
Read More
Novo Nordisk receives extended E.U. approvals for diabetes drugs
Read More
Studies assess gabapentin in cutaneous, postoperative and neuropathic pain
Read More
Lamotrigine efficacy, tolerability examined in painful diabetic neuropathy
Read More